INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Nov 01, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,000 | -- | 11,000 |
Nov 03, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 116 |
Dec 01, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,000 | $342.93 | 18,038 |
Dec 01, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Open market or private sale of non-derivative or derivative security | 1,000 | $639.13 | 17,038 |
Dec 01, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,000 | -- | 10,000 |
Dec 02, 2021 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 116 |
Dec 08, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,926 | -- | 53,883 |
Dec 08, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,494 | -- | 12,494 |
Dec 08, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,861 | -- | 318,669 |
Dec 08, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 21,198 | -- | 21,198 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.